BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus. World J Diabetes 2023; 14(6): 724-740 [PMID: 37383601 DOI: 10.4239/wjd.v14.i6.724]
URL: https://www.wjgnet.com/1948-9358/full/v14/i6/724.htm
Number Citing Articles
1
Tian-Yu Wang, Qiang Yang, Xin-Yi Cheng, Jun-Can Ding, Peng-Fei Hu. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fractionHeart Failure Reviews 2024; 30(1): 17 doi: 10.1007/s10741-024-10438-2
2
Jacob Whitman, Elie Kozaily, Erin D. Michos, Daniel N. Silverman, Marat Fudim, Robert J. Mentz, Ryan J. Tedford, Vishal N. Rao. Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future PerspectivesCurrent Heart Failure Reports 2025; 22(1) doi: 10.1007/s11897-025-00700-5
3
Nassiba Menghoum, Maria Chiara Badii, Martin Leroy, Marie Parra, Clotilde Roy, Sibille Lejeune, David Vancraeynest, Agnes Pasquet, Dulce Brito, Barbara Casadei, Christophe Depoix, Gerasimos Filippatos, Damien Gruson, Frank Edelmann, Vanessa M. Ferreira, Renaud Lhommel, Masliza Mahmod, Stefan Neubauer, Alexandre Persu, Stefan Piechnik, Kristian Hellenkamp, Ignatios Ikonomidis, Bartosz Krakowiak, Burkert Pieske, Elisabeth Pieske-Kraigher, Fausto Pinto, Piotr Ponikowski, Michele Senni, Jean-Noël Trochu, Nancy Van Overstraeten, Rolf Wachter, Bernhard L. Gerber, Jean-Luc Balligand, Christophe Beauloye, Anne-Catherine Pouleur. Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fractionCardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02688-7
4
Zhongwen Qi, Dan Wu, Zhipeng Yan, Qing Wang, Yiming Li, Junnan Zhao, Fengqin Xu. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potentialObesity Reviews 2025;  doi: 10.1111/obr.13912
5
Ruijue Huang, Wenjia Li, Zhen Xie, Kaimin Zhuo, Jing Zhu. Epicardial Adipose Tissue and Major Adverse Cardiovascular Events in Myocardial Infarction Patients with and without DiabetesAcademic Radiology 2024; 31(9): 3546 doi: 10.1016/j.acra.2024.04.001
6
Paolo Raggi, Arthur E. Stillman. Clinical Role of Epicardial Adipose TissueCanadian Journal of Cardiology 2025;  doi: 10.1016/j.cjca.2025.02.021
7
Lingyun Luo, Yuyue Zuo, Lei Dai. Metabolic rewiring and inter-organ crosstalk in diabetic HFpEFCardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02707-7
8
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, Zaiqiang Liu, Fei Gao, Zhijian Wang. Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection FractionReviews in Cardiovascular Medicine 2024; 25(9) doi: 10.31083/j.rcm2509311
9
Yuanwei Xu, Jiajun Guo, Yangjie Li, Shiqian Wang, Ke Wan, Weihao Li, Jie Wang, Ziqian Xu, Wei Cheng, Jiayu Sun, Qing Zhang, Yuchi Han, Yucheng Chen. Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathyCardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02517-3
10
Martina Vincenzi, Canan G. Nebigil. Uncovering the role of prokineticin pathway on Epicardial Adipose Tissue (EAT) development and EAT-associated cardiomyopathyTrends in Cardiovascular Medicine 2025;  doi: 10.1016/j.tcm.2025.02.006
11
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and DiabetesBiomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
12
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov. Extended-release metformin in patients with prediabetes, chro­nic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parametersDiabetes mellitus 2024; 27(4): 357 doi: 10.14341/DM13189
13
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov, E. V. Kashtanova. Long-term effects of metformin on fat depots and insulin-glucose parameters in patients with prediabetes and chronic heart failureMeditsinskiy sovet = Medical Council 2024; (16): 274 doi: 10.21518/ms2024-347